145 related articles for article (PubMed ID: 31128226)
1. MRI imaging and histopathological study of brain iron overload of β-thalassemic mice.
Yatmark P; Huaijantug S; Teerapan W; Svasti S; Fucharoen S; Morales NP
Magn Reson Imaging; 2019 Sep; 61():267-272. PubMed ID: 31128226
[TBL] [Abstract][Full Text] [Related]
2. Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca
Khamseekaew J; Kumfu S; Palee S; Wongjaikam S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
Cell Calcium; 2018 Jun; 72():18-25. PubMed ID: 29748130
[TBL] [Abstract][Full Text] [Related]
3. Deferiprone and efonidipine mitigated iron-overload induced neurotoxicity in wild-type and thalassemic mice.
Sripetchwandee J; Khamseekaew J; Svasti S; Srichairatanakool S; Fucharoen S; Chattipakorn N; Chattipakorn SC
Life Sci; 2019 Dec; 239():116878. PubMed ID: 31669736
[TBL] [Abstract][Full Text] [Related]
4. Iron distribution and histopathological characterization of the liver and heart of β-thalassemic mice with parenteral iron overload: Effects of deferoxamine and deferiprone.
Yatmark P; Morales NP; Chaisri U; Wichaiyo S; Hemstapat W; Srichairatanakool S; Svasti S; Fucharoen S
Exp Toxicol Pathol; 2014 Sep; 66(7):333-43. PubMed ID: 24907196
[TBL] [Abstract][Full Text] [Related]
5. T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients.
Hashemieh M; Azarkeivan A; Akhlaghpoor S; Shirkavand A; Sheibani K
Arch Iran Med; 2012 Feb; 15(2):91-4. PubMed ID: 22292579
[TBL] [Abstract][Full Text] [Related]
6. A combination of an iron chelator with an antioxidant exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice.
Kumfu S; Khamseekaew J; Palee S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
Free Radic Res; 2018 Jan; 52(1):70-79. PubMed ID: 29207893
[TBL] [Abstract][Full Text] [Related]
7. Deferiprone as an oral iron chelator in sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Stamoulakatou A; Meletis J; Ourailidis A; Papassotiriou I; Loukopoulos D
Ann Hematol; 2005 Jul; 84(7):434-40. PubMed ID: 15809885
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of curcuminoids in alleviation of iron overload and lipid peroxidation in thalassemic mice.
Thephinlap C; Phisalaphong C; Fucharoen S; Porter JB; Srichairatanakool S
Med Chem; 2009 Sep; 5(5):474-82. PubMed ID: 19534681
[TBL] [Abstract][Full Text] [Related]
9. Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice.
Khamseekaew J; Kumfu S; Wongjaikam S; Kerdphoo S; Jaiwongkam T; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
Eur J Pharmacol; 2017 Mar; 799():118-127. PubMed ID: 28192097
[TBL] [Abstract][Full Text] [Related]
10. A practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac T2*.
Ha SY; Mok AS; Chu WC; Raskalkar DD; Cheuk DK; Chiang AK; Ho MH; Chan GC
Hemoglobin; 2009; 33(5):323-31. PubMed ID: 19814678
[TBL] [Abstract][Full Text] [Related]
11. Combined iron chelator with N-acetylcysteine exerts the greatest effect on improving cardiac calcium homeostasis in iron-overloaded thalassemic mice.
Sumneang N; Kumfu S; Khamseekaew J; Siri-Angkul N; Fucharoen S; Chattipakorn SC; Chattipakorn N
Toxicology; 2019 Nov; 427():152289. PubMed ID: 31542421
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience.
Karakas Z; Yilmaz Y; Bayramoglu Z; Karaman S; Aydogdu S; Karagenc AO; Tugcu D; Dursun M
Radiol Med; 2018 Aug; 123(8):572-576. PubMed ID: 29663188
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic value of combined therapy with deferiprone and silymarin as iron chelators in Egyptian children with beta thalassemia major.
Hagag AA; Elfaragy MS; Elrifaey SM; Abd El-Lateef AE
Infect Disord Drug Targets; 2015; 15(3):189-95. PubMed ID: 26239735
[TBL] [Abstract][Full Text] [Related]
14. Deferiprone has less benefits on gut microbiota and metabolites in high iron-diet induced iron overload thalassemic mice than in iron overload wild-type mice: A preclinical study.
Sriwichaiin S; Thiennimitr P; Thonusin C; Sarichai P; Buddhasiri S; Kumfu S; Nawara W; Kittichotirat W; Fucharoen S; Chattipakorn N; Chattipakorn SC
Life Sci; 2022 Oct; 307():120871. PubMed ID: 35952729
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
Pipaliya N; Solanke D; Parikh P; Ingle M; Sharma R; Sharma S; Sawant P
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined deferiprone and deferoxamine chelation therapy on iron load indices in beta-thalassemia.
Tsironi M; Assimakopoulos G; Polonofi K; Rigaki K; Aessopos A
Hemoglobin; 2008; 32(1-2):29-34. PubMed ID: 18274980
[TBL] [Abstract][Full Text] [Related]
17. Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study.
Manara R; Ponticorvo S; Tartaglione I; Femina G; Elefante A; Russo C; Carafa PA; Cirillo M; Casale M; Ciancio A; Di Concilio R; De Michele E; Weiskopf N; Di Salle F; Perrotta S; Esposito F
Neuroimage Clin; 2019; 24():102058. PubMed ID: 31711032
[TBL] [Abstract][Full Text] [Related]
18. Deferiprone exerts a dose-dependent reduction of liver iron in adults with iron overload.
Binding A; Ward R; Tomlinson G; Kuo KHM
Eur J Haematol; 2019 Aug; 103(2):80-87. PubMed ID: 31066943
[TBL] [Abstract][Full Text] [Related]
19. Iron distribution and histopathological study of the effects of deferoxamine and deferiprone in the kidneys of iron overloaded β-thalassemic mice.
Yatmark P; Morales NP; Chaisri U; Wichaiyo S; Hemstapat W; Srichairatanakool S; Svasti S; Fucharoen S
Exp Toxicol Pathol; 2016 Sep; 68(8):427-34. PubMed ID: 27402198
[TBL] [Abstract][Full Text] [Related]
20. Combined iron chelator and T-type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice.
Kumfu S; Khamseekaew J; Palee S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
Eur J Pharmacol; 2018 Mar; 822():43-50. PubMed ID: 29366843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
